Cargando…

Expanded genetic insight and clinical experience of DNMT1-complex disorder

OBJECTIVE: To report novel causal mutations, expanded clinical phenotypes, and clinical management of DNA methyltransferase 1 (DNMT1)-complex disorder. METHODS: Neurophysiologic testing, imaging, and genetic findings were summarized in clinical context for 5 cases with DNMT1-complex disorder. RESULT...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Hongyan, Hojo, Kaori, Watanabe, Masashi, Yee, Christina, Maski, Kiran, Saba, Sadaf, Graff-Radford, Jonathan, Machulda, Mary M., St Louis, Erik K., Humes, Ilona Spitsyna, Flanagan, Eoin P., Nicolau, Stefan, Jones, David T., Patterson, Marc C., Kotagal, Suresh, Raz, Yael, Niu, Zhiyv, Li, Jun, Klein, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357420/
https://www.ncbi.nlm.nih.gov/pubmed/32754641
http://dx.doi.org/10.1212/NXG.0000000000000456
_version_ 1783558682461601792
author Bi, Hongyan
Hojo, Kaori
Watanabe, Masashi
Yee, Christina
Maski, Kiran
Saba, Sadaf
Graff-Radford, Jonathan
Machulda, Mary M.
St Louis, Erik K.
Humes, Ilona Spitsyna
Flanagan, Eoin P.
Nicolau, Stefan
Jones, David T.
Patterson, Marc C.
Kotagal, Suresh
Raz, Yael
Niu, Zhiyv
Li, Jun
Klein, Christopher J.
author_facet Bi, Hongyan
Hojo, Kaori
Watanabe, Masashi
Yee, Christina
Maski, Kiran
Saba, Sadaf
Graff-Radford, Jonathan
Machulda, Mary M.
St Louis, Erik K.
Humes, Ilona Spitsyna
Flanagan, Eoin P.
Nicolau, Stefan
Jones, David T.
Patterson, Marc C.
Kotagal, Suresh
Raz, Yael
Niu, Zhiyv
Li, Jun
Klein, Christopher J.
author_sort Bi, Hongyan
collection PubMed
description OBJECTIVE: To report novel causal mutations, expanded clinical phenotypes, and clinical management of DNA methyltransferase 1 (DNMT1)-complex disorder. METHODS: Neurophysiologic testing, imaging, and genetic findings were summarized in clinical context for 5 cases with DNMT1-complex disorder. RESULTS: We identified 2 novel DNMT1 mutations (p.E510K and p.P1546A) by whole-exome sequencing (WES). Case 1 (p.E510K) presented with childhood ataxia, treatment-refractory seizures, and rapid cognitive decline in his 50s. Case 2 also had childhood onset and presented with seizures, language regression, hearing loss, narcolepsy with cataplexy symptoms, optic atrophy, sensory neuropathy, and hypogammaglobulinemia requiring IV immunoglobulin. Case 2 (p.P1546A) was identified with a de novo and the first mutation residing outside the targeting sequence domain. Case 3 (p.A570V) had paralytic asymmetric onset attacks triggered by emotionality and lasting sometimes for weeks. Neuropsychological testing showed executive dysfunction localizing to frontosubcortical and frontoparietal structures. He gradually developed left predominant brain atrophy. MRI showed T2 hyperintense lesions that enhanced on T1 postgadolinium images, and brain PET showed hypometabolism in atrophied regions. Case 4 (p.T497P) underwent left cochlear implant, resulting in significant hearing improvements at all tested frequencies (250–6,000 Hz). Case 5 (p.Y511H) had profound gait ataxia with posterior column atrophy of the spinal cord and abnormal evoked potentials primarily affecting the fasciculus gracilis. CONCLUSIONS: Broader application of WES further expands genotype-phenotype correlations of DNMT1-complex disorder. Two mutations are identified with early childhood onsets. The expanded new phenotypes include asymmetric brain hemiatrophy with parenchymal gadolinium enhancement, spinal cord atrophy, prolonged cataplectic spells, and hypogammaglobulinemia. Hearing loss treatment by cochlear implantation is helpful and should be considered.
format Online
Article
Text
id pubmed-7357420
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-73574202020-08-03 Expanded genetic insight and clinical experience of DNMT1-complex disorder Bi, Hongyan Hojo, Kaori Watanabe, Masashi Yee, Christina Maski, Kiran Saba, Sadaf Graff-Radford, Jonathan Machulda, Mary M. St Louis, Erik K. Humes, Ilona Spitsyna Flanagan, Eoin P. Nicolau, Stefan Jones, David T. Patterson, Marc C. Kotagal, Suresh Raz, Yael Niu, Zhiyv Li, Jun Klein, Christopher J. Neurol Genet Article OBJECTIVE: To report novel causal mutations, expanded clinical phenotypes, and clinical management of DNA methyltransferase 1 (DNMT1)-complex disorder. METHODS: Neurophysiologic testing, imaging, and genetic findings were summarized in clinical context for 5 cases with DNMT1-complex disorder. RESULTS: We identified 2 novel DNMT1 mutations (p.E510K and p.P1546A) by whole-exome sequencing (WES). Case 1 (p.E510K) presented with childhood ataxia, treatment-refractory seizures, and rapid cognitive decline in his 50s. Case 2 also had childhood onset and presented with seizures, language regression, hearing loss, narcolepsy with cataplexy symptoms, optic atrophy, sensory neuropathy, and hypogammaglobulinemia requiring IV immunoglobulin. Case 2 (p.P1546A) was identified with a de novo and the first mutation residing outside the targeting sequence domain. Case 3 (p.A570V) had paralytic asymmetric onset attacks triggered by emotionality and lasting sometimes for weeks. Neuropsychological testing showed executive dysfunction localizing to frontosubcortical and frontoparietal structures. He gradually developed left predominant brain atrophy. MRI showed T2 hyperintense lesions that enhanced on T1 postgadolinium images, and brain PET showed hypometabolism in atrophied regions. Case 4 (p.T497P) underwent left cochlear implant, resulting in significant hearing improvements at all tested frequencies (250–6,000 Hz). Case 5 (p.Y511H) had profound gait ataxia with posterior column atrophy of the spinal cord and abnormal evoked potentials primarily affecting the fasciculus gracilis. CONCLUSIONS: Broader application of WES further expands genotype-phenotype correlations of DNMT1-complex disorder. Two mutations are identified with early childhood onsets. The expanded new phenotypes include asymmetric brain hemiatrophy with parenchymal gadolinium enhancement, spinal cord atrophy, prolonged cataplectic spells, and hypogammaglobulinemia. Hearing loss treatment by cochlear implantation is helpful and should be considered. Wolters Kluwer 2020-06-12 /pmc/articles/PMC7357420/ /pubmed/32754641 http://dx.doi.org/10.1212/NXG.0000000000000456 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Bi, Hongyan
Hojo, Kaori
Watanabe, Masashi
Yee, Christina
Maski, Kiran
Saba, Sadaf
Graff-Radford, Jonathan
Machulda, Mary M.
St Louis, Erik K.
Humes, Ilona Spitsyna
Flanagan, Eoin P.
Nicolau, Stefan
Jones, David T.
Patterson, Marc C.
Kotagal, Suresh
Raz, Yael
Niu, Zhiyv
Li, Jun
Klein, Christopher J.
Expanded genetic insight and clinical experience of DNMT1-complex disorder
title Expanded genetic insight and clinical experience of DNMT1-complex disorder
title_full Expanded genetic insight and clinical experience of DNMT1-complex disorder
title_fullStr Expanded genetic insight and clinical experience of DNMT1-complex disorder
title_full_unstemmed Expanded genetic insight and clinical experience of DNMT1-complex disorder
title_short Expanded genetic insight and clinical experience of DNMT1-complex disorder
title_sort expanded genetic insight and clinical experience of dnmt1-complex disorder
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357420/
https://www.ncbi.nlm.nih.gov/pubmed/32754641
http://dx.doi.org/10.1212/NXG.0000000000000456
work_keys_str_mv AT bihongyan expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT hojokaori expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT watanabemasashi expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT yeechristina expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT maskikiran expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT sabasadaf expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT graffradfordjonathan expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT machuldamarym expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT stlouiserikk expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT humesilonaspitsyna expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT flanaganeoinp expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT nicolaustefan expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT jonesdavidt expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT pattersonmarcc expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT kotagalsuresh expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT razyael expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT niuzhiyv expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT lijun expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder
AT kleinchristopherj expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder